Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.

J Cell Mol Med · 2013 · PMC4117550 · PMID 24251854

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendP = 0.06so close (0.05 < p ≤ 0.1)

The first study randomized 81 patients with metastatic colorectal cancer treated with fluorouracil (5-FU) to escalating doses of palifermin (2:1 randomization of palifermin to placebo) and showed a trend towards a decreased frequency of ulcerative mucositis (WHO grade 2–4): 43% versus 67%, P = 0.06.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.